922P EACH: A phase II study evaluating the safety and anti-tumour activity of avelumab and cetuximab in recurrent/metastatic squamous cell carcinomas
922P 每项：一项 II 期研究，评估阿维鲁单抗和西妥昔单抗在复发/转移性鳞状细胞癌中的安全性和抗肿瘤活性
期刊:Annals of Oncology
影响因子:65.4
doi:10.1016/j.annonc.2020.09.014
O'Callaghan, M E; Jay, A; Kichenadasse, G; Moretti, K L; Cui, W; Yousaf, N; Bhosle, J; Minchom, AR; Ahmed, M; McDonald, F; Locke, I; Lee, R; O'Brien, M; Popat, S; Lee, R; Zhou, C; Shotton, R; Tivey, A; Dickens, E; Huddar, P; McKenzie, H; Boyce, H; Maynard, A; Rowe, MP; Khan, S; Eastlake, L; Angelakas, A; Baxter, M; Copson, E; Horsley, L; Thomas, A; Wilson, C; Cooksley, T; Armstrong, A; Albiges, L; Schmidinger, M; Taguieva-Pioger, N; Perol, D; Gruenwald, V; Jazieh, AR; Akbulut, H; Curigliano, G; Rogado, A; Alsharm, AA; Razis, E; Mula-Hussain, LYI; Errihani, H; Khattak, A; De Guzman, RB; Mathias, CC; Alkaiyat, MOF; Jradi, H; Rolfo, CD; Jazieh, AR; Coutinho, AK; Bensalem, A; Alsharm, AA; Errihani, H; Mula-Hussain, LYI; Al-Sukhun, S; Sampaio-Filho, CA; Khorshid, OM; De Guzman, RB; Alkaiyat, MOF; Jradi, H; Forster, M; Metcalf, R; Sacco, J; Kong, A; Wheeler, G; Forsyth, S; Bhat, R; Blair, K; Ward, J; Lowe, H; Spanswick, V; Ensell, L; Hartley, J; White, L
